Cite

HARVARD Citation

    Farasatinasab, M. et al. (2020). Rivaroxaban as an Alternative Agent for Heparin‐Induced Thrombocytopenia. Journal of clinical pharmacology. pp. 1362-1366. [Online]. 
  
Back to record